Charles Schwab Investment Management Inc. Invests $875,000 in TruBridge, Inc. (NASDAQ:TBRG)

Charles Schwab Investment Management Inc. purchased a new stake in shares of TruBridge, Inc. (NASDAQ:TBRG - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 73,163 shares of the company's stock, valued at approximately $875,000. Charles Schwab Investment Management Inc. owned 0.49% of TruBridge as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. GAMMA Investing LLC purchased a new stake in shares of TruBridge in the 3rd quarter worth about $26,000. Covestor Ltd purchased a new position in TruBridge during the 3rd quarter valued at about $28,000. First Horizon Advisors Inc. bought a new stake in TruBridge in the third quarter worth $33,000. Point72 DIFC Ltd purchased a new stake in TruBridge during the 2nd quarter valued at about $56,000. Finally, Leavell Investment Management Inc. bought a new stake in shares of TruBridge during the third quarter valued at approximately $203,000. Institutional investors own 88.64% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the company. Stephens boosted their target price on TruBridge from $13.00 to $17.00 and gave the stock an "equal weight" rating in a research report on Wednesday, November 20th. Barclays raised their target price on shares of TruBridge from $10.00 to $14.00 and gave the stock an "equal weight" rating in a report on Monday, November 11th. Cantor Fitzgerald reissued an "overweight" rating and set a $13.00 price target on shares of TruBridge in a report on Friday, October 4th. Finally, Royal Bank of Canada reiterated an "outperform" rating and set a $14.00 price objective on shares of TruBridge in a research report on Tuesday, September 17th.

Insider Activity at TruBridge

In related news, major shareholder Pinetree Capital Ltd. acquired 3,997 shares of TruBridge stock in a transaction dated Wednesday, October 2nd. The shares were purchased at an average price of $11.93 per share, for a total transaction of $47,684.21. Following the completion of the transaction, the insider now directly owns 603,997 shares in the company, valued at approximately $7,205,684.21. This represents a 0.67 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Mark V. Anquillare bought 2,500 shares of the company's stock in a transaction that occurred on Monday, November 25th. The shares were bought at an average price of $16.81 per share, with a total value of $42,025.00. Following the transaction, the director now owns 17,178 shares of the company's stock, valued at $288,762.18. The trade was a 17.03 % increase in their position. The disclosure for this purchase can be found here. 3.60% of the stock is currently owned by corporate insiders.

TruBridge Stock Performance

Shares of NASDAQ:TBRG traded down $0.14 during midday trading on Wednesday, hitting $17.95. The company had a trading volume of 105,523 shares, compared to its average volume of 140,345. The company has a fifty day moving average of $15.35 and a two-hundred day moving average of $12.75. TruBridge, Inc. has a 12-month low of $7.55 and a 12-month high of $18.80. The company has a debt-to-equity ratio of 1.00, a current ratio of 1.80 and a quick ratio of 1.78. The company has a market cap of $267.90 million, a price-to-earnings ratio of -4.39, a PEG ratio of 70.25 and a beta of 0.69.

TruBridge Company Profile

TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.